Bio Green Med Solution declares $0.15 preferred dividend

The payment is scheduled for November 1, 2026, for preferred stockholders of record at close of business October 26, 2026.

Rhea-AI Filing Summary

Bio Green Med Solution, Inc. (BGMS) declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend is payable November 1, 2026, to stockholders of record at close of business October 26, 2026.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Quarterly cash dividend: $0.15 per share Preferred stock rate: 6% Dividend payable date: November 1, 2026 +2 more

5 metrics

Quarterly cash dividend $0.15 per share 6% Convertible Exchangeable Preferred Stock

Preferred stock rate 6% Convertible Exchangeable Preferred Stock

Dividend payable date November 1, 2026 Quarterly cash dividend

Record date October 26, 2026 Stockholders of record at close of business

Declaration date October 15, 2026 Board of Directors declared the dividend

Key Terms

Convertible Exchangeable Preferred Stock, quarterly cash dividend, stockholders of record

3 terms

Convertible Exchangeable Preferred Stock financial

"on the Company’s 6% Convertible Exchangeable Preferred Stock"

A convertible exchangeable preferred stock is a hybrid investment that pays fixed, higher-priority dividends like a bond but can later be swapped either into common shares of the issuing company or into shares of another specified company. Think of it like a coupon that gives steady income now and the option to trade it for stock later, which can boost returns but also dilute existing shareholders; investors care because it changes potential upside, income stability and ownership stakes.

quarterly cash dividend financial

"declared a quarterly cash dividend"

A quarterly cash dividend is a payment made by a company to its shareholders four times a year, usually based on its profits. It is like a regular bonus or reward for owning the company's stock, providing shareholders with income. Many investors see these payments as a sign of the company's stability and its ability to generate consistent profits.

stockholders of record financial

"to Preferred Stock stockholders of record"

Stockholders of record are the people or entities whose names appear on a company's official shareholder list on a specific cutoff date set by the company or its transfer agent; only those listed are entitled to receive dividends, vote at shareholder meetings, or participate in other corporate actions. Think of it like a guest list for an event: being on the list on the set day determines who gets the benefits and rights, so investors must own shares before the cutoff to qualify.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What dividend did BGMS declare for its preferred stock?

Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable November 1, 2026, to stockholders of record at close of business October 26, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 04:06 PM EDT Accepted by SEC EDGAR 10/16/2026 - 04:05 PM EDT Learn about SEC filing dates

false 0001130166 0001130166 2026-10-16 2026-10-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

October 16, 2026

Date of Report (date of earliest event reported)

Bio Green Med Solution, Inc.

(Exact name of Registrant as specified in its charter)

Delaware		0-50626		91-1707622
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification Number)

Level 10, Tower 11, Avenue 5, No. 8

Jalan Kerinchi, Kuala Lumpur, Malaysia 59200

(Address of principal executive offices) (Zip code)

(908) 955-0526

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		BGMS		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On October 15, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable on November 1, 2026, to Preferred Stock stockholders of record as of the close of business on October 26, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 16, 2026	Bio Green Med Solution, Inc.
	By:	/s/ Datuk Dr. Doris Wong Sing Ee
	Name:	Datuk Dr. Doris Wong Sing Ee
	Title:	Chief Executive Officer and Executive Director

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB